Hypothalamic neurons that co-express agouti-related protein (AgRP), neuropeptide Y and c-aminobutyric acid (GABA) are known to promote feeding and weight gain by integration of various nutritional, hormonal, and neuronal signals 1, 2 . Ablation of these neurons in mice leads to cessation of feeding that is accompanied by activation of Fos in most regions where they project [3] [4] [5] [6] . Previous experiments have indicated that the ensuing starvation is due to aberrant activation of the parabrachial nucleus (PBN) and it could be prevented by facilitating GABA A receptor signalling in the PBN within a critical adaptation period 5 . We speculated that loss of GABA signalling from AgRP-expressing neurons (AgRP neurons) within the PBN results in unopposed excitation of the PBN, which in turn inhibits feeding. However, the source of the excitatory inputs to the PBN was unknown. Here we show that glutamatergic neurons in the nucleus tractus solitarius (NTS) and caudal serotonergic neurons control the excitability of PBN neurons and inhibit feeding. Blockade of serotonin (5-HT 3 ) receptor signalling in the NTS by either the chronic administration of ondansetron or the genetic inactivation of Tph2 in caudal serotonergic neurons that project to the NTS protects against starvation when AgRP neurons are ablated. Likewise, genetic inactivation of glutamatergic signalling by the NTS onto N-methyl D-aspartate-type glutamate receptors in the PBN prevents starvation. We also show that suppressing glutamatergic output of the PBN reinstates normal appetite after AgRP neuron ablation, whereas it promotes weight gain without AgRP neuron ablation. Thus we identify the PBN as a hub that integrates signals from several brain regions to bidirectionally modulate feeding and body weight.
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Administration of diphtheria toxin (DT) to Agrp DTR mice, which express the human DT receptor selectively in AgRP neurons, ablates nearly all AgRP neurons in the arcuate nucleus of the hypothalamus; during the next 6 days the mice gradually cease eating, lose body weight, and die without intervention 4 . Chronic infusion of bretazenil, a partial agonist of GABA A receptor, into the PBN during the DT treatment prevents starvation and allows an adaptive process to take place such that the mice eat and maintain their body weight 5 . Not only does ablation of AgRP neurons inhibit the initiation of meals, it also decreases the amount of liquid food that will be swallowed when it is delivered directly into the mouth 7 . Because the PBN responds to visceral malaise, such as food poisoning and LiCl treatment 8 , and also processes gustatory signals in paradigms such as the conditional taste aversion or preference 9, 10 , we predicted that ablation of AgRP neurons results in unopposed activation of the PBN, which may mimic a nausea signal and thereby inhibit feeding. To test this hypothesis, we infused ondansetron, an anti-nausea drug that antagonizes 5-HT 3 receptors 11 , subcutaneously or directly into the fourth ventricle, starting 3 days before injection of Agrp DTR mice with DT. Despite the fact that the drug is administered orally to people, only central delivery of ondansetron prevented fatal weight loss and allowed the mice to recover (Fig. 1a and Supplementary  Fig. 1a ). Consumption of low-fat chow pellets by ondansetron-treated mice fell and they lost roughly 10% of their body weight during the first week after DT treatment; however, they then gradually ate more and regained body weight by 3 weeks after DT treatment (Fig. 1a and Supplementary Fig. 1a) . The 5-HT 3 receptor is an excitatory ion channel that is expressed widely in the brain, especially in the cortex and dorsal brainstem 12 . To examine more precisely where ondansetron acts to prevent starvation after AgRP neuron ablation, the drug was delivered bilaterally to either the PBN or the NTS (see Supplementary  Fig. 2 for cannula placement). Delivery of ondansetron to the PBN did not rescue the starvation phenotype of DT-treated mice, whereas delivery to the NTS prevented starvation (Fig. 1b and Supplementary Fig. 1b) . The results suggest that serotonin provides some of the excitatory drive that indirectly results in hyperactivity of the PBN after loss of inhibitory input from AgRP neurons. Neurons in the NTS are known to send excitatory, glutamatergic inputs to the PBN 13, 14 . We therefore predicted that serotonin action on 5-HT 3 receptors in the NTS promotes hyperexcitation of the PBN, which can be measured as local Fos gene activation 6 . Consistent with this hypothesis, Fos induction in the PBN was significantly ameliorated by the administration of ondansetron in the NTS (Supplementary Fig. 3 ). We conclude that inhibition of 5-HT 3 -mediated excitatory currents in the vicinity of the NTS prevents starvation after the ablation of AgRP neurons and promotes an adaptation that allows feeding to be maintained in the absence of AgRP neurons.
Tryptophan hydroxylase 2 (Tph2) catalyses the first and ratelimiting step in serotonin biosynthesis in the central nervous system 15 
.
To examine the role of serotonin more directly, conditional Tph2 lox/lox mice carrying the Agrp DTR/1 allele were generated and then injected with CAV2-Cre, a virus that is retrogradely transported from the site of injection to the cell bodies where it can inactivate the Tph2 gene only in those neurons that project to the injection site. CAV2-Cre was injected bilaterally into the NTS of Tph2 lox/lox ; Agrp DTR/1 mice, and 8 days later they were treated with DT to ablate the AgRP neurons. This viral treatment prevented the starvation that normally occurs after ablation of AgRP neurons. Feeding and body weight decreased slightly after DT treatment of the virally transduced mice, but some of the mice restored normal food intake and regained body weight ( Fig. 1c and Supplementary Fig. 1c ). Various raphe nuclei from the virally rescued Tph2 lox/lox mice were examined for serotonergic neurons that lacked Tph2 but retained L-aromatic amino acid decarboxylase (AADC), another marker of serotonergic cells. Many serotonergic cell bodies in the raphe obscurus (ROb) and raphe magnus (RMg) were found that significantly lacked Tph2 staining (Fig. 2a-l) . Quantification of the results revealed that viral treatment decreased Tph2 signalling in ROb and RMg serotonergic neurons by 60-80% (Fig. 2m) , whereas serotonergic neurons in the dorsal raphe (DR) were unaffected (Fig. 2m , and data not shown). Viral injection into the NTS of Tph2 lox/lox mice decreased serotonin levels in the NTS by about 75% (wild-type, 11.65 6 0.92 ng per mg of protein; virus-injected, 2.68 6 0.57 ng per mg of protein). Our observations are consistent with known projections of the caudal raphe neurons to brainstem structures and projections of DR neurons to forebrain regions 16 . Because many of the neurons in the NTS are known to send glutamatergic projections to the PBN 13, 14 , we predicted that serotonergic activation of the NTS might lead to glutamatergic activation of the PBN, which could be responsible for starvation after AgRP neuron ablation. To test this hypothesis, we inactivated the vesicular glutamate transporter 2 (Vglut2, encoded by the Slc17a6 gene) within the NTS by injecting AAV1-CreGFP virus bilaterally into the NTS of Slc17a6 lox/lox ; Agrp DTR/1 mice 8 days before the initiation of DT treatment (see Supplementary Fig. 4 for the placement of virus injections). Mice that were injected bilaterally and treated with DT maintained body weight and feeding, whereas mice that were unilaterally injected starved, as did mice with vehicle injection ( Fig. 3a and Supplementary Fig. 5 ). To further establish that glutamatergic activation of the PBN inhibits feeding in this model, we used a viral/genetic approach to reduce N-methyl-D-aspartate (NMDA) receptors in the PBN and thereby dampen the excitability by glutamate. Grin1 lox/lox ; Agrp DTR/1 mice, which carry two conditional alleles of the gene encoding the essential NR1 subunit of NMDA receptors and the Agrp DTR allele, were injected bilaterally with AAV1-CreGFP in the PBN 9 days before ablation of the AgRP neurons by DT (see Supplementary  Fig. 6 for the placement of virus injections). For the bilaterally injected mice, body weight declined slightly during the first 8 days after DT injection, but then recovered along with a rebound of food intake, whereas the vehicle-injected and unilaterally injected mice stopped eating and did not recover ( Fig. 3b and Supplementary Fig. 7 ). These experiments show that either decreasing glutamatergic signalling by neurons within the NTS or decreasing the number of NMDA receptors in the PBN protects against the starvation caused by the ablation of AgRP neurons. Most neurons within the PBN are glutamatergic. We therefore predicted that ; Tph2 lox/lox mice after bilateral injection of either vehicle (a-c) or a retrograding CAV2-Cre virus (d-f) into the rostral NTS. Arrowheads indicate the serotonin neurons within the ROb (B2 group) in which the expression of Tph2 was gone after viral infection. g-l, Representative immunostaining pictures of Tph2 and AADC at the RMg (B3 group) from the mice described above. Arrowheads indicate the serotonin neurons within the RMg in which the expression of Tph2 was gone after viral infection. m, Quantified immunohistochemistry results of AADC-expressing neurons that co-localized with Tph2-expressing neurons in the ROb, RMg and DR of the mice described in a-f (and data not shown). Asterisk, P , 0.01, analysis of variance (ANOVA); n 5 6 mice per group. Results are shown as means and s.e.m. Scale bar in a (for a-l), 400 mm. ;Tph2 lox/lox mice after bilateral injection of CAV2-Cre virus or vehicle into the rostral part of the NTS (rNTS). Seven of 12 mice survived the treatment with DT and viral infection (blue line). Asterisk, P , 0.05 between mice injected with CAV2-Cre (n 5 7 survivors) and vehicle into the NTS (n 5 8 non-survivors). Daggers indicate mice that were removed from the experiment when they either lost 20% of their body weight or seemed moribund. Results are shown as means 6 s.e.m.
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suppression of glutamatergic signalling by the PBN should also protect against starvation when AgRP neurons are ablated. We used the Slc17a6 lox/lox ; Agrp DTR/1 mice again for this experiment and injected AAV1-CreGFP into the lateral PBN 9 days before DT treatment ( Supplementary Fig. 5 ). The virally injected mice lost body weight during the first week after DT treatment but then gradually recovered, whereas the controls did not recover ( Fig. 3c and Supplementary Fig. 8 ).
In another cohort of mice, AAV1-CreGFP was injected into the PBN of Slc17a6 lox/lox ; Agrp DTR/1 mice, but they were not treated with DT. Those mice gained about 20% in body weight which was accompanied by about 16% increase in food intake over the next 3 weeks (Fig. 3d and Supplementary Fig. 9 ). Our results indicate that enhanced glutamatergic signalling by the PBN inhibits feeding and promotes weight loss, whereas lowering the glutamatergic output of the PBN promotes weight gain through an increase in feeding, possibly combined with a decrease in energy expenditure.
Our studies reveal six manipulations that allow mice to survive after the ablation of AgRP neurons: enhancement of GABA A receptor signalling in the PBN with bretazenil 5 ; suppression of 5-HT 3 receptor signalling in the NTS with ondansetron; disablement of serotonergic input to the NTS through viral-mediated removal of Tph2; reduction of glutamatergic signalling by the NTS by the removal of Vglut2; reduction of glutamatergic activation of the PBN by decreasing the number of NMDA receptors; or reduction of efferent glutamatergic 
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signals from the PBN. These observations support the circuit depicted in Fig. 4 . We suggest that a subpopulation of neurons in the PBN integrates visceral and gustatory information from the NTS with energy-balance signals emanating from AgRP neurons. The NTS responds to vagal inputs as well as gut-derived hormones, while AgRP neurons detect nutrient levels and respond to hormones such as insulin, leptin and ghrelin [17] [18] [19] . Consequently, the appetitive response can be modulated by food palatability and visceral condition in a manner dictated by current energy balance.
Some studies have suggested that serotonin exerts its anorectic effects by differential actions on 5-HT 1b and 5-HT 2c receptors in the hypothalamus to stimulate melanocortin signalling [20] [21] [22] , whereas a recent study indicated that serotonergic neurons in ventral raphe nuclei respond to food restriction by an elevated Fos signal 23 . We show here that serotonin from the ROb and RMg acts on 5-HT 3 receptors in the NTS to inhibit feeding after the ablation of AgRP neurons; thus, some of the anorectic effects of serotonin reuptake inhibitors, such as fenfluramine, may also be mediated in the brainstem. Classical mapping studies reveal projections from the PBN to the amygdala, thalamus, hypothalamus and other brain regions 24 . Further characterization and manipulation of PBN circuits that control feeding will be greatly facilitated by the identification of genes that are expressed exclusively by the relevant subpopulations of PBN neurons. Our experiments help define an important neural pathway within which some unique therapeutic targets have been characterized that could be valuable for the development of new treatments of various eating disorders, including nausea and anorexia nervosa 25, 26 .
METHODS SUMMARY
Agrp DTR/1 mice, Grin1 lox/lox mice and Slc17a6 lox/lox mice on a C57Bl/6 background were generated and identified genetically by PCR of tail DNA as described previously 4, 27, 28 . A conditional Tph2 targeting construct was prepared by flanking the first exon with loxP sites; the generation of Tph2 lox/lox mice on a mixed C57Bl/6 x 129/Sv background was based on standard protocols,. All experiments were performed with male mice about 8 weeks old. To ablate AgRP neurons, mice carrying the Agrp DTR allele were injected twice intramuscularly with DT (50 mg kg
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; List Biological Laboratories, Campbell); the injections were 2 days apart 4 . The extent of ablation (more than 95%) was determined by immunohistochemistry [4] [5] [6] [7] . Production of adeno-associated virus 1 (AAV1-CreGFP) and canine adenovirus 2 (CAV2-Cre) followed the protocols described previously 29, 30 . For injection of virus into the NTS or PBN, mice were anaesthetized and virus was injected bilaterally or unilaterally through a 5-ml Hamilton syringe. For drug treatments, Alzet 14-day minipumps (model 1002) loaded with 100 ml of ondansetron (6 mg ml
; Sigma-Aldrich) were implanted subcutaneously on the back of anaesthetized mice 4 days before DT treatment. Alternatively, cannulas (28 gauge; Plastics One) were placed into fourth ventricles and connected by tubing with the subcutaneous minipumps that were loaded with ondansetron (0.6 mg ml
). For feeding assays, mice were transferred to BioDAQ Food and Water Intake Monitor (Research Diets) supplied with water and low-fat chow diet (D12450B). The mice were allowed to acclimatize for 3 days before the initiation of each experiment and data collection. Body weight and total food intake were recorded every 24 h. Feeding and drinking activity was recorded in accordance with the manufacturer's suggested protocol.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Animal maintenance and neuron ablation. Mice were housed in a temperatureand humidity-controlled facility with a 12-h light cycle. All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Washington. In compliance with our approved protocol, all experiments were terminated if the body weight of mice fell to 80% of their original body weight or they seemed moribund. Agrp DTR/1 mice, Grin1 lox/lox mice and Slc17a6 lox/lox mice were generated and genetically identified by PCR of tail DNA as described previously 4, 27, 28 . A conditional Tph2 targeting construct was prepared by flanking the first exon with loxP sites along with a frt-flanked SV-Neo gene in the first intron. The construct was electroporated in G4 ES cells, and correctly targeted clones were identified by Southern blotting. After removal of the Sv-Neo gene by breeding with a mouse expressing FLP recombinase, heterozygotes were bred to generate Tph2 lox/lox mice that were used for viral injection. Details are available from the authors on request.
All except Tph2 lox/lox mice were on the C57Bl/6 background (more than nine generations backcrossed); Tph2 lox/lox mice were on a mixed 129/Sv ; List Biological Laboratories, Campbell); the injections were 2 days apart 4 . The extent of ablation (more than 95%) was determined by immunohistochemistry [4] [5] [6] [7] . Viral injections. Production of adeno-associated virus 1 (AAV1-CreGFP) and canine adenovirus 2 (CAV2-Cre) followed the protocols described previously 29, 30 . For injection of CAV2-Cre or AAV1-CreGFP virus into the rostral NTS, mice were anaesthetized and virus (or PBS as the vehicle) was injected bilaterally or unilaterally (1 ml of roughly 10 10 particles per ml each side) through a Hamilton syringe (size 5 ml; Hamilton, Reno), using stereotactic coordinates 60.8 mm (x axis), 27.1 mm (y axis) and 24.3 mm (z axis). Similarly, AAV1-CreGFP virus (or PBS as the vehicle) was injected into the PBN bilaterally or unilaterally, using stereotactic coordinates 61.0 mm (x axis), 25.3 mm (y axis) and 23.3 mm (z axis). Brain samples from all mice were collected at the end of the behavioural experiment and processed for immunohistological analysis. For all viral injection experiments, only a fraction (indicated in figure legends) of the DT-treated mice survived AgRP-neuron ablation; subsequent evaluation of CreGFP expression revealed that failure to rescue was associated with poor placement or inadequate viral transduction. Drug treatments. Alzet 14-day minipumps (model 1002; Durect, Cupertino) loaded with 100 ml of ondansetron (6 mg ml 21 in saline; Sigma-Aldrich, St Louis) were implanted subcutaneously on the back of anaesthetized mice 4 days before DT treatment. These minipumps dispense 0.25 ml h
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. Alternatively, cannulas (28 gauge; Plastics One, Roanoke) were placed into fourth ventricles under anaesthesia and the subcutaneous minipumps, which were loaded with ondansetron (0.6 mg ml 21 in saline), were connected to the cannulas by tubing (PE60; Stoelting, Wood Dale) that was threaded under the skin to help prevent the mice from dislodging it. For some experiments, the minipumps (ondansetron, 0.6 mg ml
) were connected to bilateral cannulas (28 gauge; Plastics One) directed to specific brain regions by using the following stereotactic coordinates: PBN, 61 mm (x axis), 25.3 mm (y axis) and 23.3 mm (z axis); NTS, 60.8 mm (x axis), 27.1 mm (y axis) and 24.3 mm (z axis). The patency and placement of the bilateral minipump were verified at the end of each experiment, and brain samples were processed for immunohistological analysis. Food intake and body weight measurements. For feeding assays, mice were transferred to BioDAQ Food and Water Intake Monitor (Research Diets, New Brunswick) supplied with water and low-fat (3.85 kcal ml
) chow diet (D12450B; Research Diets). The mice were allowed to acclimatize for 3 days before initiation of each experiment and data collection. Body weight and total food intake were recorded every 24 h. Feeding and drinking activity was recorded in accordance with the manufacturer's suggested protocol. Immunohistochemistry. Mice were killed by CO 2 asphyxiation and perfused transcardially with ice-cold PBS buffer containing 4% paraformaldehyde. Brains were dissected and postfixed overnight at 4 uC in the fixation buffer. Free-floating brain sections (25 mm) were washed three times in PBS containing 0.1% Triton X-100 (PBST buffer) solution (15 min each wash) and then blocked with 3% normal donkey serum in PBST for 2-3 h at about 23 uC. Rabbit anti-AgRP (dilution 1:1,500; Phoenix Pharmaceuticals, Belmont), rabbit anti-Fos (dilution 1:1,000; Millipore, Temecula), monoclonal anti-tryptophan hydroxylase (dilution 1:1,500; Sigma-Aldrich) and rabbit anti-dopa decarboxylase (equivalent to AADC; dilution 1:500; Millipore) were applied to the sections for incubation overnight at 4 uC, followed by three 15-min rinses in PBST. Finally, sections were incubated in Cy2-or Cy3-labelled secondary antibody (dilution 1:300; Jackson Immunolaboratory, West Grove) before visualization. Images were captured with a digital camera mounted on a Leica TCS SP1 confocal microscope (Leica Microsystems); all paired photos were obtained through the same system settings. For each group of mice, at least eight sections from four different mice were analysed. Data analyses. Quantification of Tph2-positive and AADC-positive cells was performed with the NIH Image software (National Institutes of Health). Anatomical correlations of brain sections and delineation of individual nuclei were determined by comparing landmarks of Nissl staining images with those given in the stereotactic atlas. From the anatomically matched sections, a region of interest of the same size was further defined. Meanwhile, an optimized threshold that can discern round nuclei from partly stained ones as well as background noise was preset for all measurements. For all experiments only those mice with correct placement of cannula or viral injections were compared with the control group. Unless otherwise stated, data sets collected from all experiments were analysed by one-way ANOVA followed by the Student-Newman-Keuls method for statistical significance; results were plotted as means 6 s.e.m. Posthoc analysis was performed when group differences were significant by ANOVA at P , 0.05.
